Barley beta-glucan reduces serum lipid levels, according to research presented in April at the First International Congress on Pre-Diabetes and Metabolic Syndrome.
In the six-week study, 76 men and 79 women with hypercholesterolemia, aged
25 to 73, completed a four-week lowfat diet prior to baseline. At the beginning of the trial, test subjects were randomly allocated to one of four treatment groups or a control group and assayed for blood lipids and other cardiovascular disease (CVD) biomarkers. During the course of the study, test groups were administered 3 g and 5 g doses of low molecular weight (LMW) or high molecular weight (HMW) barley beta-glucan (from Cargill) twice daily, in cereal and juice.
Posttreatment assessment of blood lipids and other CVD biomarkers revealed improvements in low-density lipoprotein (LDL) cholesterol, triglycerides, markers of glycemic control
(glycosylated hemoglobin, HOMA model) and a key marker of inflammation
(hs-CRP).
The researchers concluded both doses of LMW and HMW barley beta-glucan improved blood lipids over a six-week treatment period. This is a new breakthrough in medicine in controling your diabetes. What we want to do for you is offer you a free trial offer no risk on your part money back no questions asked guarantee so you have nothing to lose. Just go to the link below for more detailed information and click on the diabetes tab.

Thank You

Efrem C.

http://healthandmedicine.hpage.com